Cancer Research Institute Announces 2026 CLIP and Technology Impact Awards, Fueling Next-Generation Immunotherapies
admin The Cancer Research Institute (CRI), a global leader in advancing immunotherapy, has proudly announced the...
biotech
Johnson & Johnson Secures Option to Acquire Sail Biomedicines, Marking Major Bet on In Vivo CAR-T for Autoimmune Diseases
Pharmaceutical giant Johnson & Johnson has taken a significant step into the burgeoning field of...
Susumu Tonegawa, PhD, Nobel Laureate and Pioneering Molecular Biologist, Passes Away at 86, Leaving an Indelible Mark on Immunology and Neuroscience
The scientific community is in mourning following the passing of Susumu Tonegawa, PhD, a towering...
Alnylam Pharmaceuticals Faces Sharp Market Reversal as Amvuttra Sales Miss and Guidance Cut Trigger 30% Stock Plunge
Cambridge, MA – Alnylam Pharmaceuticals, a pioneering force in RNA interference (RNAi) therapeutics, experienced a...
Paving the Path to a Cancer-Free Future: The Enduring Impact of Legacy Gifts to the Cancer Research Institute
Including the Cancer Research Institute (CRI) in your will represents a profoundly personal and impactful...
FDA Advisory Panel Recommends Replimune’s RP1 for Advanced Melanoma, Overriding Agency Scientist Concerns and Paving Way for Crucial Approval
In a pivotal decision that could redefine treatment pathways for a challenging subset of melanoma...
Safeguarding Your Skin: Unpacking UV Radiation Risks, Prevention, and the Immunotherapy Revolution Against Skin Cancer
July marks Ultraviolet (UV) Radiation Safety Awareness Month, an annual observance underscoring the critical importance...
Hims & Hers Faces Federal Scrutiny Over Allegations of Health Data Sharing and Deceptive Subscription Practices
A federal lawsuit filed in California has cast a significant shadow over Hims & Hers,...
Sarcoma Awareness Month: Unpacking the Complexities and Emerging Hope of Immunotherapy
Sarcoma, a rare and notably complex group of cancers, has historically presented significant therapeutic challenges,...
Vertex Pharmaceuticals Partners with AbCellera to Advance T-Cell Engagers for Autoimmune Diseases, Bolstering Diversification Efforts
Vertex Pharmaceuticals, a biopharmaceutical giant predominantly known for its transformative cystic fibrosis treatments, has officially...
